- Report
- April 2021
United States
From €3037EUR$3,450USD£2,625GBP
- Report
- April 2021
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- March 2021
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- August 2020
- 86 Pages
Europe
From €3037EUR$3,450USD£2,625GBP
- Report
- May 2024
- 145 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- March 2022
- 124 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- May 2024
- 116 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- May 2024
- 100 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- November 2023
- 148 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- February 2024
- 180 Pages
Global
From €1100EUR$1,250USD£951GBP
€2201EUR$2,500USD£1,902GBP
- Report
- February 2026
- 153 Pages
Canada
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 162 Pages
China
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 154 Pages
Germany
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 155 Pages
India
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 150 Pages
Canada
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 150 Pages
China
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 150 Pages
Germany
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 150 Pages
India
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 150 Pages
Canada
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 150 Pages
China
From €4270EUR$4,850USD£3,690GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more